MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers

Casey L Ross1, Shivani Kaushik2, Rodrigo Valdes-Rodriguez1

  • 1Department of Dermatology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.

Insights

MicroRNAs (miRNAs) are key to understanding melanoma development. This review highlights their crucial roles in melanoma progression and their potential as biomarkers for early detection and treatment response.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Melanoma is the deadliest form of skin cancer, with rising incidence rates.
  • Understanding melanoma's molecular drivers is essential for improved diagnosis, prognosis, and treatment.
  • Early detection significantly improves melanoma survival rates.

Purpose of the Study:

  • To review current data on microRNAs (miRNAs) involved in melanoma.
  • To explore the potential of miRNAs as diagnostic and prognostic biomarkers for melanoma.
  • To highlight the role of miRNAs in melanoma cell proliferation, migration, invasion, apoptosis, and immune response.

Main Methods:

  • Review of current scientific literature on microRNA expression profiling in melanoma.
  • Analysis of identified miRNAs' roles in melanoma cell biology.
  • Evaluation of miRNA potential as diagnostic and prognostic indicators.

Main Results:

  • MicroRNA expression profiling has identified key miRNAs in melanoma.
  • These miRNAs are implicated in critical processes such as cell proliferation, migration, invasion, and apoptosis.
  • Specific miRNAs show promise as biomarkers for melanoma detection and predicting treatment outcomes.

Conclusions:

  • MicroRNAs play a significant role in the molecular mechanisms of melanomagenesis.
  • miRNAs hold considerable potential as valuable diagnostic and prognostic biomarkers for melanoma.
  • Further research into miRNAs could lead to improved early detection and personalized treatment strategies for melanoma patients.